FrancophonIA/ELRC3.0 huggingface dataset:
English: • diarrhoea
Slovenian: Žilne bolezni
English: It is not known if febuxostat may harm your unborn child. Febuxostat Mylan should not be used during pregnancy.
Slovenian: Zdravila Febuksostat Mylan med nosečnostjo ne smete jemati.
English: Febuxostat Mylan 80 mg film-coated tablets febuxostat
Slovenian: Febuksostat Mylan 80 mg filmsko obložene tablete febuksostat
English: Febuxostat C showed a superior and faster urate lowering activity compared to allopurinol.
Slovenian: V primerjavi z alopurinolom je febuksostat imel boljši in hitrejši učinek na zmanjšanje sečne kisline.
English: No significant difference in mean serum creatinine change (%) occurred between febuxostat and allopurinol (-0.83 ± 26.98 vs -4.92 ± 16.70 respectively; least square means difference: 4.0970 [95% confidence interval: -0.6467 ; 8.8406]; p=0.0903).
Slovenian: Srednja vrednost spremembe kreatinina pri febuksostatu in alopurinolu ni bila pomembna (-0,83 ± 26,98 proti -4,92 ± 16,70; razlika povprečne vrednosti najmanjšega kvadrata:
English: Lactose
Slovenian: Dojenje
English: Pharmacokinetic modelling and simulation of rat data suggests that, when co-administered with febuxostat, the clinical dose of mercaptopurine/azathioprine should be reduced to 20% or less of the previously prescribed dose in order to avoid possible haematological effects (see section 4.4 and 4.5).
Slovenian: Farmakokinetično modeliranje in simulacija podatkov, pridobljenih pri podganah, kaže, da je potrebno kliničen odmerek merkaptopurina/azatioprina ob sočasnem jemanju s febuksostatom, zmanjšati na 20 % ali manj prvotno predpisanega odmerka, da se izognemo morebitnim hematološkim učinkom (glejte poglavji 4.4 in 4.5).
English: SUN
Slovenian: NED
English: Based on modelling and simulation analysis of data from a pre-clinical study in rats, when coadministered with febuxostat, the dose of mercaptopurine/azathioprine should be reduced to the 20% or less of the previously prescribed dose in order to avoid possible haematological effects (see section 4.5 and 5.3).
Slovenian: Na podlagi modeliranja in simulacije analiznih podatkov iz predkliničnih študij, izvedenih na podganah, se mora odmerek merkaptopurina/azatioprina, ob sočasnem jemanju s febuksostatom, zmanjšati na 20 % ali manj prvotno predpisanega odmerka, da se izognemo morebitnim hematološkim učinkom (glejte poglavji 4.5 in 5.3).
English: Nervousness
Slovenian: Febuksostat
English: SAT
Slovenian: SOB
English: Gout
Slovenian: ČET
English: Febuxostat Mylan 80 mg and 120 mg film-coated tablets are available in plastic bottles of 28
Slovenian: 80-miligramske in 120-miligramske filmsko obložene tablete Febuksostat Mylan so na voljo v plastenkah s po 28 in 84 tabletami.
English: Febuxostat Mylan 80 mg film-coated tablets
Slovenian: Febuksostat Mylan 80 mg filmsko obložene tablete
English: Renal failure, nephrolithiasis, haematuria, pollakiuria, proteinuria Rare
Slovenian: Občasni odpoved ledvic, nefrolitiaza, hematurija, polakisurija, proteinurija Redki tubulointersticijski nefritis*, nuja po odvajanju urina
English: No statistically significant differences were found and no causal relationship with febuxostat was established.
Slovenian: Vzročna povezava s febuksostatom ni bila dokazana.
English: Prevention and treatment of high uric acid levels in patients undergoing cancer chemotherapy Febuxostat Mylan is available as a 120 mg tablet.
Slovenian: Zdravilo Febuksostat Mylan je na voljo kot 120 mg tableta.
English: • reddening of the skin (erythema), rash in various types (e.g. itchy, with white spots, with blisters, with blisters containing pus, with shedding of the skin, measles-like rash),
Slovenian: • rdečina kože (eritem), različni tipi izpuščajev (npr. srbeč, z belimi pikami, z mehurčki, z gnojnimi mehurčki, z luščenjem kože, noricam podoben izpuščaj), razširjena rdečina kože, nekroza, mehurjasto odstopanje povrhnjice in membran sluznice, ki se kaže kot luščenje in možnost nastanka sepse (Stevens-Johnson sindrom/toksična epidermalna nekroliza).
English: The ability of febuxostat to lower serum uric acid levels was prompt and persistent.
Slovenian: Febuksostat je takoj in dolgotrajno znižal vrednosti sečne kisline v serumu.
English: España
Slovenian: Francija
English: How to store Febuxostat Mylan
Slovenian: Kaj vsebuje zdravilo Febuksostat Mylan
English: The recommended dose in patients with mild hepatic impairment is 80 mg. Limited information is available in patients with moderate hepatic impairment.
Slovenian: Priporočeni odmerek pri bolnikih z blago okvaro jeter je 80 mg.
English: EU/1/17/1194/014 EU/1/17/1194/015 EU/1/17/1194/016 EU/1/17/1194/023 EU/1/17/1194/024 EU/1/17/1194/025 EU/1/17/1194/026 EU/1/17/1194/027 EU/1/17/1194/028
Slovenian: EU/1/17/1194/009 EU/1/17/1194/010 EU/1/17/1194/011 EU/1/17/1194/012 EU/1/17/1194/013 EU/1/17/1194/014 EU/1/17/1194/015 EU/1/17/1194/016 EU/1/17/1194/023 EU/1/17/1194/024 EU/1/17/1194/025 EU/1/17/1194/026 EU/1/17/1194/027 EU/1/17/1194/028
English: THU
Slovenian: TOR
English: Febuxostat achieved the primary efficacy endpoint in 44% (80 mg QD), 45% (120 mg QD), and 60% (240 mg QD) of patients compared to 0% in the allopurinol 100 mg QD and placebo groups.
Slovenian: Pri bolnikih z okvaro ledvic, ki so bili naključno razporejeni v skupino, ki je prejemala alopurinol, je bila višina odmerka omejena na 100 mg enkrat na dan. Primarni opazovani dogodek učinkovitosti je bil v skupini, ki je jemala febuksostat, dosežen pri 44 % (80 mg enkrat na dan), 45 % (120 mg enkrat na dan) in 60 % (240 mg enkrat na dan) bolnikov v primerjavi z 0 % v skupinah, ki so prejemale 100 mg alopurinola enkrat na dan ali placebo.
English: • hair loss
Slovenian: • glavobol,
English: Mylan Pharmaceuticals, S.L Tel: + 34 900 102 712
Slovenian: Tel: + 34 900 102 712
English: EU/1/17/1194/007 EU/1/17/1194/008 EU/1/17/1194/017 EU/1/17/1194/018 EU/1/17/1194/019 EU/1/17/1194/020 EU/1/17/1194/021 EU/1/17/1194/022
Slovenian: EU/1/17/1194/001 EU/1/17/1194/002 EU/1/17/1194/003 EU/1/17/1194/004 EU/1/17/1194/005 EU/1/17/1194/006 EU/1/17/1194/007 EU/1/17/1194/008 EU/1/17/1194/017 EU/1/17/1194/018 EU/1/17/1194/019 EU/1/17/1194/020 EU/1/17/1194/021 EU/1/17/1194/022
English: Metabolism and nutrition disorders
Slovenian: Bolezni jeter in žolčevodov
English: EU Number
Slovenian: EU številka
English: Invented name
Slovenian: Izmišljeno ime
English: Content Package size
Slovenian: Ovojnina Vsebina Velikost pakiranja
English: Packaging
Slovenian: Karenca
English: The European Commission issued a decision on 5 September 2013.
Slovenian: Evropska komisija je sklep izdala dne 5. septembra 2013.
English: • allergies, including severe allergic reactions;
Slovenian: • alergije, vključno s hudimi alergijskimi reakcijami;
English: The company wanted the authorisation to be recognised in Germany and the Netherlands (the ‘concerned Member States').
Slovenian: Družba je želela, da se dovoljenje prizna v Nemčiji in na Nizozemskem (v „zadevnih državah članicah“).
English: • organ transplantation.
Slovenian: • presaditev organov.
English: It is available as an oral solution (6mg/ml).
Slovenian: Na voljo je v obliki peroralne raztopine (6 mg/ml).
English: Why was Okrido reviewed?
Slovenian: Zakaj je bilo zdravilo Okrido pregledano?
English: However, the Member States were not able to reach an agreement and the United Kingdom referred the matter to the CHMP for arbitration on 5 March 2013.
Slovenian: Vendar države članice niso mogle doseči soglasja, zato je Združeno kraljestvo 5. marca 2013 zadevo napotilo odboru CHMP v arbitražo.
English: Okrido is a generic medicine based on a ‘reference medicine' already authorised in the EU.
Slovenian: Okrido je generično zdravilo na osnovi na „referenčnega zdravila“, ki je že odobreno v EU.
English: In particular, as the two medicines contain different excipients (inactive ingredients), the Netherlands considered that further studies were needed to show that these differences did not result in relevant differences in the way the two medicines are absorbed by the body.
Slovenian: Predvsem zato, ker zdravili vsebujeta različne pomožne snovi (neaktivne sestavine), je Nizozemska menila, da so potrebne dodatne študije, s katerimi bi pokazali, da te razlike ne povzročajo pomembnih razlik v načinu absorpcije teh dveh zdravil v telesu.
English: • diseases of the lungs (including asthma), upper airways (croup), blood vessels and heart, bowel or kidneys, muscles and joints (including rheumatoid arthritis) or the eye or nervous system;
Slovenian: • bolezni pljuč (vključno z astmo), zgornjih dihal (krup), krvnih žil in srca, črevesja ali ledvic, mišic in sklepov (vključno z revmatoidnim artritisom) ter oči ali živčevja;
English: On 27 June 2013, the European Medicines Agency completed an arbitration procedure following a disagreement among Member States of the European Union (EU) regarding the authorisation of the medicine Okrido.
Slovenian: Evropska agencija za zdravila je dne 27. junija 2013 zaključila arbitražni postopek, do katerega je prišlo zaradi nesoglasja med državami članicami Evropske unije (EU) glede odobritve dovoljenja za promet z zdravilom Okrido.
English: • skin conditions;
Slovenian: • bolezni kože;
English: What is Okrido?
Slovenian: Kaj je zdravilo Okrido?
English: • some cancers, including leukaemia, lymphoma and myeloma;
Slovenian: • nekatere vrste raka, vključno z levkemijo, limfomom in mielomom;
English: Pharmapol Arzneimittelvertrieb GmbH submitted Okrido for mutual recognition on the basis of the initial authorisation granted by the United Kingdom's Medicines and Healthcare products Regulatory Agency on 19 April 2010.
Slovenian: Družba Pharmapol Arzneimittelvertrieb GmbH je predložila vlogo za medsebojno priznavanje zdravila Okrido na podlagi prvotnega dovoljenja za promet, ki ga je dne 19. aprila 2010 odobrila Regulativna agencija Združenega kraljestva za zdravila in medicinske pripomočke.
English: Okrido is used to treat a range of inflammatory and auto-immune conditions (diseases caused by the body's own defence system attacking normal tissue) including:
Slovenian: Zdravilo Okrido se uporablja za zdravljenje različnih vnetnih in avtoimunskih bolezni (tj. bolezni, pri katerih obrambni sistem telesa napada normalno tkivo), med katere spadajo:
English: Based on an evaluation of the currently available data and the scientific discussion within the Committee, the CHMP concluded that, based on the data submitted, Okrido is expected to produce comparable levels of the active substance in the body to the reference medicine.
Slovenian: Na podlagi ocene trenutno razpoložljivih podatkov in znanstvene razprave znotraj odbora je CHMP zaključil, da je na podlagi predloženih podatkov mogoče predvideti, da bo zdravilo Okrido zagotovilo ravni zdravilne učinkovine v telesu, primerljive z referenčnim zdravilom.
English: The active substance in Okrido, prednisolone sodium phosphate, belongs to a group of medicines called glucocorticoids, which are substances that help to reduce inflammation.
Slovenian: Zdravilna učinkovina v zdravilu Okrido, prednizolon natrijev fosfat, spada v skupino zdravil, ki jih imenujemo glukokortikoidi in so snovi, ki pomagajo zmanjšati vnetje.
English: Okrido is a medicine that contains the active substance prednisolone sodium phosphate.
Slovenian: Okrido je zdravilo, ki vsebuje zdravilno učinkovino prednizolon natrijev fosfat.
English: The Agency's Committee for Medicinal Products for Human Use (CHMP) concluded that the benefits of Okrido outweighs its risks, and the marketing authorisation granted in the United Kingdom can be recognised in other Member States of the EU.
Slovenian: Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da so koristi zdravila Okrido večje od z njim povezanih tveganj in da se dovoljenje za promet, ki je bilo odobreno v Združenem kraljestvu, lahko prizna v drugih državah članicah EU.
English: The reference medicine was Prednisolone 5 mg soluble tablets by Sovereign.
Slovenian: Referenčno zdravilo je bilo zdravilo Prednisolone 5 mg tablete za peroralno raztopino družbe Sovereign.
English: The grounds for the referral were that sufficient data had not been provided to show that Okrido produces comparable levels of the active substance in the body to Prednisolone 5 mg soluble tablets by Sovereign.
Slovenian: Razlog za napotitev je bilo dejstvo, da niso bili predloženi zadostni podatki, ki bi dokazovali, da zdravilo Okrido zagotovi podobne ravni zdravilne učinkovine v telesu kot zdravilo Prednisolone 5 mg tablete za peroralno raztopino družbe Sovereign.
English: The CHMP therefore concluded that the benefits of Okrido outweigh its risks, and therefore the marketing authorisation for Okrido should be granted in all concerned Member States.
Slovenian: CHMP je zato zaključil, da so koristi zdravila Okrido večje od z njim povezanih tveganj, in priporočil odobritev dovoljenja za promet z njim v vseh zadevnih državah članicah.
English: This summary was last updated in March 2018.
Slovenian: Povzetek je bil nazadnje posodobljen marca 2018.
English: Further information on Metacam can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Slovenian: Nadaljnje informacije o zdravilu Metacam so na voljo na spletni strani agencije: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: These side effects occur usually within the first week of treatment and are generally transient (temporary).
Slovenian: Običajno se ti učinki pojavijo v prvem tednu zdravljenja in so po navadi prehodni (začasni).
English: Metacam (meloxicam)
Slovenian: Metacam (meloksikam)
English: The European Medicines Agency decided that Metacam's benefits are greater than its risks and that it can be authorised for use in the EU.
Slovenian: Evropska agencija za zdravila je zaključila, da so koristi zdravila Metacam večje od z njim povezanih tveganj in da se lahko odobri za uporabo v EU.
English: Injections may be into a vein, muscles or under the skin.
Slovenian: Injekcije se dajejo v veno, mišico ali pod kožo.
English: In very rare cases, they may be serious or fatal.
Slovenian: V zelo redkih primerih so lahko resni ali povzročijo celo pogin.
English: Metacam received a marketing authorisation valid throughout the EU for Metacam on 7 January 1998.
Slovenian: Zdravilo Metacam je pridobilo dovoljenje za promet, veljavno po vsej Evropski uniji, 7. januarja 1998.
English: All sows also received antibiotics.
Slovenian: Vse svinje so dobile tudi antibiotik.
English: Why is Metacam approved in the EU?
Slovenian: Zakaj je bilo zdravilo Metacam odobreno v EU?
English: If the product is accidentally swallowed or self-injected by a person, the advice of a doctor should be sought immediately.
Slovenian: Če človek zdravilo nenamerno zaužije ali samoinjicira, se je treba nemudoma posvetovati z zdravnikom.
English: The study showed that the dogs receiving meloxicam injection followed by oral doses had the best results in improving mobility based on a standard scoring system.
Slovenian: Študija je pokazala, da so imeli psi, ki so prejeli injekcijo meloksikama, ki ji je sledilo peroralno jemanje zdravila, najboljše rezultate pri izboljšani gibljivosti na podlagi standardnega sistema točkovanja.
English: What are the risks associated with Metacam?
Slovenian: Kakšna tveganja so povezana z zdravilom Metacam?
English: People who are hypersensitive (allergic) to NSAIDs should avoid contact with Metacam.
Slovenian: Osebe, ki so preobčutljive za (alergične na) nesteroidna protivnetna zdravila, se morajo izogibati stiku z zdravilom Metacam.
English: Other information about Metacam
Slovenian: Druge informacije o zdravilu Metacam
English: What is Metacam and what is it used for?
Slovenian: Kaj je zdravilo Metacam in za kaj se uporablja?
English: What benefits of Metacam have been shown in studies?
Slovenian: Kakšne koristi je zdravilo Metacam izkazalo v študijah?
English: The main measure of effectiveness was the assessment of pain score at various time points up to 20 hours post-surgery.
Slovenian: Glavno merilo učinkovitosti je bila ocena bolečine v različnih časovnih točkah do 20 ur po kirurškem posegu.
English: An overview of Metacam and why it is authorised in the EU
Slovenian: Pregled zdravila Metacam in zakaj je odobreno v EU
English: Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.
Slovenian: Metacam je protivnetno zdravilo, ki se uporablja za zdravljenje govedi, prašičev, konjev, psov, mačk in morskih prašičkov.
English: For the 20 mg/ml and 40 mg/ml solution for injection the meat withdrawal period is 5 days and for the 15 mg/ml oral suspension it is 3 days.
Slovenian: Pri uporabi 20 in 40 mg/ml raztopine za injiciranje je karenca za meso pet dni, pri uporabi 15 mg/ml peroralne suspenzije pa tri dni.
English: In cattle, pigs and horses in very rare cases anaphylactoid reactions which may be serious (including fatal) may occur and should be treated symptomatically.
Slovenian: Pri govedu, prašičih in konjih se lahko v zelo redkih primerih pojavijo anafilaktične reakcije, ki utegnejo biti zelo resne (celo smrtne) in jih je treba zdraviti simptomatsko.
English: A temporary swelling at the injection site can occur but resolves without intervention.
Slovenian: Lahko se pojavi prehodna oteklina na mestu injiciranja, vendar ta izzveni brez ukrepanja.
English: The withdrawal period is 15 days for meat and 5 days for milk.
Slovenian: Karenca je 15 dni za meso in pet dni za mleko.
English: The product is not authorised to use in horses producing milk for human consumption.
Slovenian: Zdravilo ni odobreno za uporabo pri konjih, katerih mleko je namenjeno prehrani ljudi.
English: For further information about using Metacam, see the package leaflet or contact your veterinarian or pharmacist.
Slovenian: Za več informacij o uporabi zdravila Metacam glejte navodilo za uporabo ali se posvetujte z veterinarjem ali farmacevtom.
English: These side effects resolve once treatment has stopped.
Slovenian: Ti neželeni učinki so izginili, kakor hitro se je zdravljenje zaključilo.
English: Another study in cattle involved 501 calves with diarrhoea.
Slovenian: Druga študija pri govedu je zajela 501 tele z drisko.
English: Metacam was effective in improving mobility and reducing pain from day 0-14 compared to the control group.
Slovenian: Zdravilo Metacam je bilo učinkovito pri izboljšanju gibljivosti in lajšanju bolečine 0-14 dni v primerjavi s kontrolno skupino.
English: The withdrawal period for meat is 5 days.
Slovenian: Karenca za meso je pet dni.
English: In very rare cases anaphylactoid reactions and elevated liver enzymes have been reported.
Slovenian: V zelo redkih primerih so poročali o anafilaktičnih reakcijah in povišanju jetrnih encimov.
English: 46 cats received Metacam oral suspension for 28 days whilst 48 cats received placebo oral suspension.
Slovenian: 46 mačk je 28 dni prejemalo zdravilo Metacam v obliki peroralne suspenzije, medtem ko je 48 mačk prejemalo peroralno suspenzijo brez zdravilne učinkovine.
English: Meloxicam acts by blocking an enzyme called cyclooxygenase which is involved in the production of prostaglandins.
Slovenian: Meloksikam deluje tako, da zavira encim, imenovan ciklooksigenaza, ki sodeluje pri tvorjenju prostaglandinov.
English: All calves were given oral rehydration therapy and antibiotics.
Slovenian: Vsa teleta so prejela zdravila za peroralno rehidracijo in antibiotike.
English: The main measure of effectiveness was blood levels of the stress hormone cortisol 30 minutes after surgery.
Slovenian: Glavno merilo učinkovitosti je bila raven stresnega hormona - kortizola v krvi 30 minut po kirurškem posegu.
English: The 40 mg/ml solution for injection should not be handled by pregnant women or women attempting to conceive as accidental self-injection may affect the development of the baby in the womb.
Slovenian: Z zdravilom v obliki 40 mg/ml raztopine za injiciranje naj ne rokujejo nosečnice ali ženske, ki bi rade zanosile, saj lahko vpliva na razvoj otroka v maternici.
English: Metacam contains meloxicam, which belongs to a class of medicines called non-steroidal antiinflammatory drugs (NSAIDs).
Slovenian: Zdravilo Metacam vsebuje meloksikam, ki spada v skupino zdravil, ki jim pravimo nesteroidna protivnetna zdravila (NSAID).
English: In one study three different meloxicam treatment schedules for acute locomotor disorders were compared.
Slovenian: V eni študiji so primerjali tri režime zdravljenja akutnih lokomotornih obolenj.
English: The main measure of effectiveness was based on clinical signs of diarrhoea and the animal's behaviour, feed intake, body temperature, respiratory rate, heart rate and general condition.
Slovenian: Glavno merilo učinkovitosti so bili klinični znaki driske in vedenje živali, ješčnost, telesna temperatura, hitrost dihanja in bitje srca ter splošno stanje živali.
English: The effectiveness of Metacam injection was studied in 209 pigs with non-infectious locomotor disorders.
Slovenian: Učinkovitost zdravila Metacam v obliki injekcije je bila proučena pri 209 prašičih z nenalezljivimi lokomotornimi obolenji.
English: Guinea pigs treated with Metacam had significantly higher frequency of feed intake (240 events) over three days, indicating that their pain was reduced, compared with guinea pigs given placebo (207 events).
Slovenian: Morski prašički, zdravljeni z zdravilom Metacam, so imeli v treh dneh bistveno večji vnos krme (240 dogodkov), kar kaže, da so v primerjavi z morskimi prašički, ki so dobili placebo (207 dogodkov), imeli manj bolečin.
English: 37 cats received Metacam and 39 cats received carprofen (another NSAID) by subcutaneous (under the skin) injection immediately after receiving anaesthesia.
Slovenian: 37 mačk je prejelo zdravilo Metacam, 39 pa karprofen (drugo nesteroidno protivnetno zdravilo) s podkožno injekcijo takoj po prejetju anestezije.
English: In addition to antibiotic therapy animals either received a single injection of Metacam or flunixin (another NSAID) for up to 5 days.
Slovenian: Poleg antibiotikov so živali do pet dni prejemale bodisi eno injekcijo zdravila Metacam ali fluniksin (drugo nesteroidno protivnetno zdravilo).
English: A laboratory study in 30 guinea pigs compared Metacam oral suspension with placebo given about 45 minutes before surgical castration and on each of the following two days.
Slovenian: V laboratorijski študiji na 30 morskih prašičkih so primerjali zdravilo Metacam v obliki peroralne suspenzije s placebom, danima 45 minut pred operativno kastracijo in dva naslednja dneva.
English: The main measure of effectiveness was based on their general condition, milk appearance and signs of udder inflammation.
Slovenian: Glavno merilo učinkovitosti je bilo splošno stanje živali, videz mleka in znaki vnetja vimena.
English: Metacam was comparable to flunixin in treating signs of infection and inflammation associated with puerperal septicaemia and toxaemia.
Slovenian: Zdravilo Metacam je bilo primerljivo s fluniksinom, kar zadeva zdravljenje znakov okužbe in vnetja, povezanih s puerperalno septikemijo in toksemijo.
English: Metacam treated piglets had significantly reduced blood cortisol levels (which indicates that they were exposed to lower levels of stress) 30 minutes after castration compared with the control group.
Slovenian: Pujski, ki so prejeli zdravilo Metacam, so imeli 30 minut po kastraciji v krvi občutno nižje ravni kortizola (kar kaže, da so bili izpostavljeni nižji ravni stresa) v primerjavi s kontrolno skupino.
English: The formulation and dose to use depends on the animal species, its bodyweight and the condition being treated.
Slovenian: Formulacija in višina odmerka sta odvisni od vrste živali, njene telesne mase in vrste bolezni, ki se zdravi.
English: The withdrawal period is the time allowed after administration of the medicine before an animal can be slaughtered and the meat used for human consumption.
Slovenian: Obdobje karence je čas, ki mora preteči po uporabi zdravila, preden se lahko žival zakolje in meso uporabi za prehrano ljudi.